Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Immunology and Cell Biology|August 25, 2022
What is Kindness in Science and why does it matter?Jessica Boulter, Mariana Lizeth Orozco Morales, Nicola Principe, et al.
Frontiers in Oncology|May 14, 2021
Malignant Pleural Effusions-A Window Into Local Anti-Tumor T Cell Immunity?Nicola Principe, Joel Kidman, Richard A Lake, et al.
Epigenetics|August 20, 2019
Impaired T cell proliferation by <i>ex vivo</i> BET-inhibition impedes adoptive immunotherapy in a murine melanoma modelJonathan Chee, Chelsea Wilson, Anthony Buzzai, et al.
Frontiers in Immunology|November 9, 2020
Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy ResponsesJoel Kidman, Nicola Principe, Mark Watson, et al.
Frontiers in Immunology|May 31, 2022
Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive CombinationsNicola Principe, Wayne J Aston, Danika E Hope, et al.
Clinical & Translational Immunology|November 3, 2022
Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by a JAK1/JAK2 inhibitorTingting Ge, Amber-Lee Phung, Gaurang Jhala, et al.
Journal for Immunotherapy of Cancer|September 29, 2024
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockadeNicola Principe, Amber-Lee Phung, Kofi L P Stevens, et al.
Cell Reports|April 27, 2022
Interferons limit autoantigen-specific CD8<sup>+</sup> T-cell expansion in the non-obese diabetic mouseGaurang Jhala, Balasubramanian Krishnamurthy, Thomas C Brodnicki, et al.
Cell Reports|December 28, 2022
CD4<sup>+</sup> T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapyCaitlin M Tilsed, Nicola Principe, Joel Kidman, et al.
Pageof 2